Related Experiment Video
Updated: Jul 28, 2026

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
Published on: May 2, 2011
HIV vaccine research: the way forward
Anthony S Fauci1, Margaret I Johnston, Carl W Dieffenbach
1National Institute of Allergy and Infectious Diseases, National Institutes of Health, 31 Center Drive, Bethesda, MD 20892, USA. afauci@niaid.nih.gov
Prioritizing HIV vaccine research is crucial, emphasizing laboratory, nonhuman primate (NHP), and clinical studies. Key actions include enhancing NHP models and fostering collaboration to accelerate HIV/AIDS vaccine discovery amid budget constraints.
Area of Science:
- Immunology
- Vaccinology
- Infectious Diseases
Background:
- Fundamental questions in HIV vaccine discovery require expanded research across multiple disciplines.
- Attracting and retaining young researchers is vital for sustained progress in HIV vaccine development.
- Developing improved nonhuman primate (NHP) models and strengthening the link between NHP and clinical research are critical needs.
Purpose of the Study:
- To summarize the current progress and challenges in HIV vaccine research.
- To outline the priorities established at a recent summit by the National Institute of Allergy and Infectious Diseases (NIAID).
- To identify necessary actions to advance HIV vaccine discovery within budgetary limitations.
Main Methods:
- Review of current HIV vaccine research landscape.
- Analysis of priorities from a NIAID summit on HIV vaccine research.
- Identification of strategic actions for resource allocation and research focus.
Main Results:
- Emphasis on broadening research scope in HIV vaccine discovery.
- Need for enhanced NHP models and integrated NHP-clinical research.
- Prioritization of HIV/AIDS vaccine research efforts is necessary for efficient resource allocation.
Conclusions:
- Strategic prioritization and focused actions are essential to energize HIV vaccine discovery.
- Strengthening research infrastructure, including NHP models and researcher development, is key.
- Continued and coordinated efforts across laboratory, NHP, and clinical research are imperative for developing an effective HIV vaccine.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
Vaccinations
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics
Vaccine Production
Vaccines

